Morgan Stanley lowered the firm’s price target on Bowhead Specialty (BOW) to $29 from $31 and keeps an Equal Weight rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty’s Q3 2025 Earnings: Strong Growth Amid Challenges
- Bowhead Specialty Holdings Reports Strong Q3 2025 Results
- Bowhead Specialty Reports Strong Q3 Financial Results
- Bowhead Specialty reports Q3 adjusted EPS 47c, consensus 41c
- Bowhead Specialty price target lowered to $40 from $43 at Citizens JMP